Janus Henderson Group PLC Purchases Shares of 166,410 Hill-Rom Holdings Inc (HRC)

Janus Henderson Group PLC purchased a new stake in Hill-Rom Holdings Inc (NYSE:HRC) in the second quarter, according to its most recent filing with the SEC. The fund purchased 166,410 shares of the medical technology company’s stock, valued at approximately $13,248,000. Janus Henderson Group PLC owned about 0.25% of Hill-Rom Holdings at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Shelton Capital Management bought a new stake in shares of Hill-Rom Holdings in the 2nd quarter valued at approximately $362,000. Flinton Capital Management LLC increased its holdings in shares of Hill-Rom Holdings by 322.6% in the 2nd quarter. Flinton Capital Management LLC now owns 15,232 shares of the medical technology company’s stock valued at $1,213,000 after acquiring an additional 11,628 shares during the last quarter. Fred Alger Management Inc. increased its holdings in shares of Hill-Rom Holdings by 163.3% in the 2nd quarter. Fred Alger Management Inc. now owns 9,217 shares of the medical technology company’s stock valued at $734,000 after acquiring an additional 5,717 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of Hill-Rom Holdings by 38.9% in the 2nd quarter. Royal Bank of Canada now owns 4,959 shares of the medical technology company’s stock valued at $395,000 after acquiring an additional 1,390 shares during the last quarter. Finally, Balyasny Asset Management LLC increased its holdings in shares of Hill-Rom Holdings by 127.2% in the 2nd quarter. Balyasny Asset Management LLC now owns 50,602 shares of the medical technology company’s stock valued at $4,028,000 after acquiring an additional 28,328 shares during the last quarter. Institutional investors and hedge funds own 82.31% of the company’s stock.

In related news, SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Andreas G. Frank sold 6,870 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,293,993.48. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “Janus Henderson Group PLC Purchases Shares of 166,410 Hill-Rom Holdings Inc (HRC)” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://ledgergazette.com/2017/10/21/janus-henderson-group-plc-purchases-shares-of-166410-hill-rom-holdings-inc-hrc.html.

A number of brokerages have recently weighed in on HRC. KeyCorp reiterated a “buy” rating and issued a $82.00 price target on shares of Hill-Rom Holdings in a report on Tuesday. Zacks Investment Research upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, October 3rd. BidaskClub upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research note on Sunday, August 6th. Stifel Nicolaus restated a “buy” rating and set a $84.00 price objective on shares of Hill-Rom Holdings in a research note on Sunday, July 30th. Finally, Cantor Fitzgerald set a $86.00 price objective on Hill-Rom Holdings and gave the stock a “hold” rating in a research note on Friday, July 28th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Hill-Rom Holdings presently has a consensus rating of “Buy” and a consensus price target of $86.83.

Hill-Rom Holdings Inc (HRC) opened at 81.19 on Friday. The company’s 50-day moving average price is $76.37 and its 200-day moving average price is $76.46. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a market capitalization of $5.35 billion, a P/E ratio of 47.31 and a beta of 1.19.

Hill-Rom Holdings (NYSE:HRC) last posted its earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Shelton Capital Management bought a new stake in shares of Hill-Rom Holdings in the 2nd quarter valued at approximately $362,000. Flinton Capital Management LLC increased its holdings in shares of Hill-Rom Holdings by 322.6% in the 2nd quarter. Flinton Capital Management LLC now owns 15,232 shares of the medical technology company’s stock valued at $1,213,000 after acquiring an additional 11,628 shares during the last quarter. Fred Alger Management Inc. increased its holdings in shares of Hill-Rom Holdings by 163.3% in the 2nd quarter. Fred Alger Management Inc. now owns 9,217 shares of the medical technology company’s stock valued at $734,000 after acquiring an additional 5,717 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of Hill-Rom Holdings by 38.9% in the 2nd quarter. Royal Bank of Canada now owns 4,959 shares of the medical technology company’s stock valued at $395,000 after acquiring an additional 1,390 shares during the last quarter. Finally, Balyasny Asset Management LLC increased its holdings in shares of Hill-Rom Holdings by 127.2% in the 2nd quarter. Balyasny Asset Management LLC now owns 50,602 shares of the medical technology company’s stock valued at $4,028,000 after acquiring an additional 28,328 shares during the last quarter. Institutional investors and hedge funds own 82.31% of the company’s stock.

In related news, SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Andreas G. Frank sold 6,870 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,293,993.48. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “Janus Henderson Group PLC Purchases Shares of 166,410 Hill-Rom Holdings Inc (HRC)” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://ledgergazette.com/2017/10/21/janus-henderson-group-plc-purchases-shares-of-166410-hill-rom-holdings-inc-hrc.html.

A number of brokerages have recently weighed in on HRC. KeyCorp reiterated a “buy” rating and issued a $82.00 price target on shares of Hill-Rom Holdings in a report on Tuesday. Zacks Investment Research upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, October 3rd. BidaskClub upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research note on Sunday, August 6th. Stifel Nicolaus restated a “buy” rating and set a $84.00 price objective on shares of Hill-Rom Holdings in a research note on Sunday, July 30th. Finally, Cantor Fitzgerald set a $86.00 price objective on Hill-Rom Holdings and gave the stock a “hold” rating in a research note on Friday, July 28th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Hill-Rom Holdings presently has a consensus rating of “Buy” and a consensus price target of $86.83.

Hill-Rom Holdings Inc (HRC) opened at 81.19 on Friday. The company’s 50-day moving average price is $76.37 and its 200-day moving average price is $76.46. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a market capitalization of $5.35 billion, a P/E ratio of 47.31 and a beta of 1.19.

Hill-Rom Holdings (NYSE:HRC) last posted its earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. Hill-Rom Holdings’s revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the company earned $0.81 EPS. On average, equities analysts forecast that Hill-Rom Holdings Inc will post $3.82 EPS for the current fiscal year.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply